Growth Analyser Growth Analyser

Compare funds

Pick up to 10 funds. Compare funds from the same category for a fair reading.

UTI Innovation Fund · Direct ✕HDFC Pharma and Healthcare Fund · Direct ✕

Growth of ₹10,000

Basics

UTI Innovation FundHDFC Pharma and Healthcare Fund
CategorySectoral / ThematicSectoral / Thematic
PlanDirectDirect
Fund houseUTIHDFC
NAV₹11.5430₹23.6750
NAV date20 Nov 202620 Nov 2026
History3.1 years3.1 years
Expense ratio1.2%1.1%
Stars★★★★★★★★★★
Growth Score3.4094.50

Returns

UTI Innovation FundHDFC Pharma and Healthcare Fund
1 month+1.76%+12.97%
3 months−7.15%+7.13%
6 months+5.97%+17.84%
YTD−2.64%+33.73%
1 year−5.57%+32.20%
3 years (CAGR)+3.34%+30.70%
5 years (CAGR)——
10 years (CAGR)——
Since launch+4.69%+31.83%

Risk

UTI Innovation FundHDFC Pharma and Healthcare Fund
Volatility21.0%15.8%
Downside volatility14.7%8.5%
Sharpe−0.151.53
Sortino−0.222.86
Calmar0.112.06
Return / risk0.161.95
Deepest fall−31.51%−14.91%
Days to recover—126
Below its high−13.98%+0.00%

Against benchmark

UTI Innovation FundHDFC Pharma and Healthcare Fund
Alpha−6.64%+7.54%
Beta1.010.97
R²59.5%85.0%
Up capture81.0%108.9%
Down capture116.0%71.0%
Tracking error13.3%6.1%
Information ratio−0.501.17
Treynor−0.030.24

Consistency

UTI Innovation FundHDFC Pharma and Healthcare Fund
Best 1-year+29.07%+67.01%
Middle 1-year−1.59%+23.25%
Worst 1-year−13.79%+1.71%
1-year periods with a loss60.1%0.0%
Middle 3-year+4.18%+30.22%
Positive months55.6%72.2%
Best day+4.68%+3.18%
Worst day−4.42%−3.61%
Worst 5% day−2.02%−1.51%
Positive days54.9%58.3%
NAVs a year247247

SIP of ₹10,000 a month

UTI Innovation FundHDFC Pharma and Healthcare Fund
5-year XIRR——
5-year value——
3-year XIRR+1.28%+27.71%
1-year XIRR+5.32%+41.37%

Holdings overlap i

Overlap needs the monthly portfolio filing of at least two of these funds; not loaded yet.

Search Growth